Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Consort Medical plc    CSRT   GB0000946276

CONSORT MEDICAL PLC

(CSRT)
  Report
 SummaryNewsRatingsCompanyFinancials 
Financials
Sales 2018 311 M 425 M 425 M
Net income 2018 16,1 M 22,0 M 22,0 M
Net Debt 2018 95,5 M 130 M 130 M
P/E ratio 2018 36,7x
Yield 2018 1,75%
Sales 2019 305 M 416 M 416 M
Net income 2019 10,5 M 14,3 M 14,3 M
Net Debt 2019 97,4 M 133 M 133 M
P/E ratio 2019 43,5x
Yield 2019 2,32%
Capitalization 499 M 640 M 682 M
EV / Sales 2018 2,20x
EV / Sales 2019 1,80x
Nbr of Employees 2 000
Free-Float 86,1%
More Financials
Company
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its... 
More about the company
All news about CONSORT MEDICAL PLC
2020RECIPHARM PUBL : completes delisting of Consort Medical
AQ
2020RECIPHARM PUBL : will be implementing squeeze-out of Consort Medical shares
AQ
2020RECIPHARM PUBL : has announced that Consort Medical will apply for delisting
AQ
2020RECIPHARM PUBL : has announced that Consort Medical will apply for delisting
AQ
2020RECIPHARM PUBL : announces that Consort Medical applies for delisting
AQ
2020RECIPHARM PUBL : Group - Consort Medical becomes part of the Group
AQ
2020RECIPHARM PUBL : Consort Medical becomes part of the Recipharm Group
AQ
2020CONSORT MEDICAL : Form 8.3 - CONSORT MEDICAL PLC
PU
2020CONSORT MEDICAL : Additional Listing
PU
2020CONSORT MEDICAL : Form 8.3 -
PU
2020CONSORT MEDICAL : Form 8.5 (EPT/RI) - Consort Medical plc
AQ
2020CONSORT MEDICAL : Form 8.3 - Consort Medical PLC
PU
2020CONSORT MEDICAL : Form 8.5 (EPT/RI)
PU
2020CONSORT MEDICAL : Response to Recipharm Statement
PU
2020CONSORT MEDICAL : Form 8.3 - CSRT LN
PU
More news
News in other languages on CONSORT MEDICAL PLC
2019CONSORT MEDICAL PLC : Consort Medical accepte l'offre du Suédois Recipharm AB
2019Des idées d'actions britanniques pour jouer le(s) Brexit(s)
2017CONSORT MEDICAL PLC : Veröffentlichung des Halbjahresergebnisses
2017CONSORT MEDICAL PLC : publication des résultats semestriels
2017CONSORT MEDICAL PLC : Veröffentlichung des Jahresergebnisses
More news
Income Statement Evolution
Managers and Directors
NameTitle
William John Jenkins Senior Independent Non-Executive Director
Ian James Nicholson Independent Non-Executive Director
Andrew Joseph Hosty Independent Non-Executive Director
Paul Hayes Director
Andrew Jackson Secretary & Group General Counsel
Sector and Competitors
1st jan.Capitalization (M$)
CONSORT MEDICAL PLC-1.46%628
ABBOTT LABORATORIES4.78%196 561
MEDTRONIC PLC-0.20%157 350
BECTON, DICKINSON AND COMPANY4.00%75 691
HOYA CORPORATION-3.92%49 122
ALIGN TECHNOLOGY, INC.0.95%42 537